These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28740336)

  • 21. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.
    Xu X; Yu T; Shi J; Chen X; Zhang W; Lin T; Liu Z; Wang Y; Zeng Z; Wang C; Li M; Liu C
    J Biol Chem; 2014 Mar; 289(13):8881-90. PubMed ID: 24532795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and the regulation of Wnt/beta-catenin signaling and innate immunity in colorectal cancer.
    Byers S; Shah S
    Nutr Rev; 2007 Aug; 65(8 Pt 2):S118-20. PubMed ID: 17867386
    [No Abstract]   [Full Text] [Related]  

  • 24. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
    Ortega P; Morán A; de Juan C; Frías C; Hernández S; López-Asenjo JA; Sánchez-Pernaute A; Torres A; Iniesta P; Benito M
    Clin Cancer Res; 2008 Feb; 14(4):995-1001. PubMed ID: 18281531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells.
    Thomas M; Bayha C; Vetter S; Hofmann U; Schwarz M; Zanger UM; Braeuning A
    Mol Pharmacol; 2015 Jun; 87(6):1013-20. PubMed ID: 25824487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
    Rahmani F; Avan A; Hashemy SI; Hassanian SM
    J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Wnt and β-catenin Expression in Advanced Colorectal Cancer.
    Yoshida N; Kinugasa T; Ohshima K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y
    Anticancer Res; 2015 Aug; 35(8):4403-10. PubMed ID: 26168479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
    Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
    J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
    Raghu D; Karunagaran D
    J Nat Prod; 2014 May; 77(5):1130-4. PubMed ID: 24828199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
    Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
    Bahrami A; Amerizadeh F; ShahidSales S; Khazaei M; Ghayour-Mobarhan M; Sadeghnia HR; Maftouh M; Hassanian SM; Avan A
    J Cell Biochem; 2017 Aug; 118(8):1979-1983. PubMed ID: 28109136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.
    Zhang J; Tsoi H; Li X; Wang H; Gao J; Wang K; Go MY; Ng SC; Chan FK; Sung JJ; Yu J
    Gut; 2016 Sep; 65(9):1482-93. PubMed ID: 26071132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis.
    Anwar M; Kochhar R; Singh R; Bhatia A; Vaiphei K; Mahmood A; Mahmood S
    Mol Carcinog; 2016 Nov; 55(11):1627-1638. PubMed ID: 26373808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.